Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer

Precise biomarkers are needed to guide better diagnostics and therapeutics for basal-like breast cancer, for which DNA-dependent protein kinase catalytic subunit (DNA-PKcs) has been recently reported by the Clinical Proteomic Tumor Analysis Consortium as the most specific biomarker. We evaluated DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Asleh, Karama, Riaz, Nazia, Cheng, Angela S., Gao, Dongxia, Leung, Samuel C. Y., Anurag, Meenakshi, Nielsen, Torsten O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429676/
https://www.ncbi.nlm.nih.gov/pubmed/34504086
http://dx.doi.org/10.1038/s41523-021-00320-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429676/
https://www.ncbi.nlm.nih.gov/pubmed/34504086
http://dx.doi.org/10.1038/s41523-021-00320-x

Ejemplares similares